Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome. [PDF]
OBJECTIVE: The aim of our study was to evaluate the associations between arterial stiffness indexes and immune-inflammatory markers in subjects with acute ischemic stroke with and without metabolic syndrome.
Arnao, V.+10 more
core +2 more sources
Effect of hyperthermia on prognosis after acute ischemic stroke [PDF]
<p><b>Background and Purpose:</b> Experimental studies have shown that hyperthermia is a determinant of poor outcome after ischemic stroke.
Kamruzzaman, A.+4 more
core +1 more source
The relationship between oxidative stress and acute ischemic stroke severity and functional outcome
Background Cerebral ischemia initiates an oxidative stress response in the brain which is a composite process that involves many oxidative stress biomarkers. High levels of malondialdehyde (MDA) in patients with acute ischemic stroke had been found.
Wael M. Elsayed+3 more
doaj +1 more source
Overview of Acute Ischemic Stroke Evaluation and Management
Stroke is a major contributor to death and disability worldwide. Prior to modern therapy, post-stroke mortality was approximately 10% in the acute period, with nearly one-half of the patients developing moderate-to-severe disability. The most fundamental
Tasneem F. Hasan+2 more
doaj +1 more source
Arterial stiffness and ischemic stroke in subjects with and without metabolic syndrome. [PDF]
We conducted a study to evaluate arterial stiffness markers in subjects with acute ischemic stroke and metabolic syndrome and in relation to TOAST subtype of stroke. We enrolled 130 patients with acute ischemic stroke and metabolic syndrome, 127 patients
Arnao, V.+7 more
core +1 more source
Non-coding RNAs in acute ischemic stroke: from brain to periphery
Acute ischemic stroke is a clinical emergency and a condition with high morbidity, mortality, and disability. Accurate predictive, diagnostic, and prognostic biomarkers and effective therapeutic targets for acute ischemic stroke remain undetermined. With
Shuo Li+9 more
doaj +1 more source
Immunodepression as A Risk Factor of Infection in Patients with Acute Ischemic Stroke [PDF]
Background: Immunodepression is an absence or deficient supply of the components of either humoral or cellular immunity, or both. Previous studies show that the central nervous system and the immune system interact in complex ways.
Wirastuti, K. (Ken )
core +1 more source
Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke.
Background and Purpose- TNK (tenecteplase), a newer fibrinolytic agent, has practical delivery advantages over ALT (alteplase) that would make it a useful agent if noninferior in acute ischemic stroke treatment outcome.
A. Burgos, J. Saver
semanticscholar +1 more source
The Impact of Inter-Hospital Transfer on Clinical Outcomes following Endovascular Treatment for Acute Ischemic Stroke [PDF]
PURPOSE Hospitals designated as primary stroke centers offer noninvasive treatment for acute ischemic stroke, but only comprehensive stroke centers are equipped to provide endovascular treatment.
Schmidt, Tyler
core +1 more source
Background and Purpose- Circular RNAs (CircRNAs) show promise as stroke biomarkers because of their participation in various pathophysiological processes associated with acute ischemic stroke (AIS) and stability in peripheral blood.
L. Zuo+15 more
semanticscholar +1 more source